Octavio Espinoza - Sep 20, 2024 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role
Chief Financial Officer
Signature
By: /s/ Andrew Reardon, Attorney-in-Fact For: Octavio Espinoza
Stock symbol
LGND
Transactions as of
Sep 20, 2024
Transactions value $
-$132,518
Form type
4
Date filed
9/24/2024, 07:41 PM
Previous filing
Sep 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Sale -$20.8K -200 -0.77% $103.98 25.7K Sep 20, 2024 Direct
transaction LGND Common Stock Sale -$28.6K -275 -1.07% $103.86 25.4K Sep 20, 2024 Direct
transaction LGND Common Stock Sale -$83.2K -800 -3.15% $103.95 24.6K Sep 20, 2024 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.